Article Versions Notes

Ampatzidou M, Papadhimitriou SI, Paisiou A, Paterakis G, Tzanoudaki M, Papadakis V, Florentin L, Polychronopoulou S. The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols. Diagnostics. 2023; 13(9):1589. https://doi.org/10.3390/diagnostics13091589

Ampatzidou, Mirella, Stefanos I. Papadhimitriou, Anna Paisiou, Georgios Paterakis, Marianna Tzanoudaki, Vassilios Papadakis, Lina Florentin, and Sophia Polychronopoulou. 2023. "The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols" Diagnostics 13, no. 9: 1589. https://doi.org/10.3390/diagnostics13091589

Ampatzidou, M., Papadhimitriou, S. I., Paisiou, A., Paterakis, G., Tzanoudaki, M., Papadakis, V., Florentin, L., & Polychronopoulou, S. (2023). The Prognostic Effect of CDKN2A/2B Gene Deletions in Pediatric Acute Lymphoblastic Leukemia (ALL): Independent Prognostic Significance in BFM-Based Protocols. Diagnostics, 13(9), 1589. https://doi.org/10.3390/diagnostics13091589